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Abstract
Pseudomonas aeruginosa is an opportunistic pathogen causing severe respiratory infections. The pathogenesis of these infections is multi-
factorial and the production of many virulence factors is regulated by quorum sensing (QS), a cell-to-cell communication mechanism.
The two well deﬁned QS systems in P. aeruginosa, the las and rhl systems, rely on N-acyl homoserine lactone signal molecules, also
termed autoinducers. We assessed the activity of QS-dependent virulence factors (including elastase, alkaline protease, pyocyanin and
bioﬁlm production) in respiratory isolates of P. aeruginosa and their relationship with antimicrobial susceptibility. We identiﬁed sixteen
isolates displaying impaired phenotypic activity; among them, eleven isolates were also defective in autoinducer production, and there-
fore considered QS-deﬁcient. Six of the QS-deﬁcient isolates failed to amplify one or more of the four QS regulatory genes (lasI, lasR,
rhlI, rhlR) with PCR: one isolate was negative for rhlR, two isolates were negative for rhlI and rhlR and three isolates were negative for
all four genes. The isolates that were negative for virulence factor production were generally less susceptible to the antimicrobials and
statistically signiﬁcant correlations were observed between the lack of elastase production and resistance to piperacillin and ceftazidime;
between failure in alkaline protease production and resistance to tobramycin, piperacillin, piperacillin-tazobactam, cefepime, imipenem
and ciproﬂoxacin; and between failure in pyocyanin production and resistance to amikacin, tobramycin, ceftazidime, ciproﬂoxacin and
oﬂoxacin. The results obtained indicate that, despite the pivotal role of QS in the pathogenesis of P. aeruginosa respiratory infections,
QS-deﬁcient strains are still capable of causing infections and tend to be less susceptible to antimicrobials.
Keywords: Antimicrobial susceptibility, Pseudomonas aeruginosa, quorum sensing, virulence
Original Submission: 28 September 2009; Revised Submission: 11 January 2010; Accepted: 17 January 2010
Editor: R. Canto´n
Article published online: 2 February 2010
Clin Microbiol Infect 2010; 16: 1770–1775
10.1111/j.1469-0691.2010.03177.x
Corresponding author: A. Yagci, Marmara University, School of
Medicine, Department of Microbiology, 34668, Haydarpasa, Istanbul,
Turkey
E-mail: ayagci@marmara.edu.tr
Introduction
Pseudomonas aeruginosa is an opportunistic human pathogen
with remarkable metabolic versatility, which allows it to
thrive in diverse natural and nosocomial conditions. Infec-
tions as a result of P. aeruginosa are rare in otherwise healthy
individuals but common in the compromised, such as patients
with cystic ﬁbrosis (CF), severe burns, or those with
impaired immunity as seen in patients infected with HIV or
in cancer patients undergoing chemotherapy [1]. The respira-
tory system is the most frequent body site infected, often
presenting as acute ventilator-associated pneumonia in noso-
comial settings or chronic destructive lung disease in patients
suffering from CF [2]. The pathogenesis of P. aeruginosa lung
infections is multifactorial and depends on numerous viru-
lence factors, including the secreted factors such as elastase,
alkaline protease, phospholipase C, exotoxin A, exoenzyme
S, pyocyanin, pyoverdine, hydrogen cyanide, rhamnolipid and
cell-associated factors, such as lipopolysaccharide, ﬂagella and
pili [1,3,4]. Another factor contributing to pathogenesis of
P. aeruginosa is its tendancy to form organized communities,
known as bioﬁlms when it attaches to biotic or abiotic
surfaces.
In recent years, it has been discovered that the produc-
tion of many virulence factors and the formation of bioﬁlm
by P. aeruginosa is regulated by a cell-to-cell communication
mechanism known as quorum sensing (QS) [5,6]. The two
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well-deﬁned QS systems in P. aeruginosa, namely las and rhl,
rely on N-acyl homoserine lactone (AHL) signal molecules,
also termed autoinducers. The las system is comprised of
the transcriptional regulatory protein LasR, its cognate
autoinducer molecule N-(3-oxododecanoyl) homoserine lac-
tone (3OC12-HSL) and the AHL synthase LasI. Similarly, the
rhl system consists of RhlR, its cognate autoinducer molecule
N-butyryl homoserine lactone (C4-HSL) and the AHL syn-
thase RhlI [7]. When a critical threshold concentration of
autoinducer is reached, the autoinducer molecule binds to
its cognate transcriptional regulatory protein. The autoinduc-
er-transcriptional regulatory protein complex in turn triggers
the expression of many target genes, along with the AHL
synthase, thus creating a positive feedback loop [6]. Although
the las and rhl systems are two separate QS systems, they
are related in a hierarchical manner, with the las system
being dominant over the rhl system [8].
The essential role of QS in the pathogenesis of P.
aeruginosa respiratory infections has been demonstrated in
various animal models, although its importance in human lung
infections remains speculative because QS-deﬁcient isolates
have been obtained from such infections [9–12]. In the pres-
ent study, we aimed to assess the activity of QS-dependent
virulence factors in clinically pathogenic respiratory isolates
of P. aeruginosa and their relationship with antimicrobial sus-
ceptibility, another important virulence factor of P. aeruginosa.
Materials and Methods
Bacterial strains and growth conditions
The clinical P. aeruginosa isolates used in the present study
were collected by the clinical microbiology laboratory at
Marmara University, School of Medicine, Istanbul, Turkey,
between the years 2005 and 2006. One hundred bacterial
isolates obtained from lower respiratory clinical samples
(sputum n = 53, tracheal aspirate n = 37, bronchoalveolar
lavage n = 10) were presumptively identiﬁed as P. aeruginosa
by biochemical tests and further identiﬁed to the species
level using automated identiﬁcation systems (Vitek 2, bio-
Me´rieux, l’Etoile, France; Phoenix, Becton-Dickinson, Becton-
Dickinson Biosciences, Franklin Lakes, NJ, USA). To discrimi-
nate between respiratory colonization and infection, the
CDC guidelines were strictly followed and only clinical
strains isolated from infections were included in the study
[13]. To minimize clonal relatedness, only one isolate per
patient was used in the study and patients were selected so
that 35 of the isolates were from outpatients, 29 were from
patients hospitalized in two different intensive care units
(ICU) and 36 were from clinics other than ICU. The isolates
were stored at )80C in cryopreservation vials (Cryobank,
Mast Diagnostics, Bootle, UK). Frozen stock cultures were
used to inoculate the subcultures which were routinely
grown in Luria Bertani (LB) broth (Difco, Franklin Lakes, NJ,
USA) overnight at 37C. Secondary media were inoculated
as necessary for different assays. Secondary media included
LB broth for elastin congo red, alkaline protease and bioﬁlm
assays (at 37C for 16 h), LB agar (Difco) for micro-AHL
cross-feeding bioassay. Glycerol alanine minimal medium (per
litre: 10 mL glycerol, 6 g L-alanine, 2 g MgSO4, 0.1 g
K2HPO4, 0.018 g FeSO4, sterilized in autoclave at 121C for
15 min) was employed for pyocyanin assay (at 37C for
24 h) [9]. P. aeruginosa PAO1 wild-type strain was used as
positive control for phenotypic and genotypic tests.
P. aeruginosa PAO-JP2 (DlasI, DrhlI mutant) and PAO-JP3
(DlasR, DrhlR mutant) strains were used as negative controls
for phenotypic tests [14].
Elastin Congo red assay
The elastolytic activity of LasB elastase within the superna-
tant fraction of isolates was assayed using elastin congo red
as substrate. Brieﬂy, the cells were grown in LB broth at
37C for 16 h, centrifuged at 15 000 g at 4C for 10 min
and 0.5 mL supernatant was added to 1 mL of assay buffer
(30 mM Tris buffer, pH 7.2) containing 10 mg of elastin
Congo red (Sigma, Poole, UK). The mixture was incubated
at 37C for 6 h with constant rotation, insoluble substrate
was pelleted with centrifugation at 1200 g for 10 min and
absorbance of the supernatant was measured at 495 nm
[15]. Assays were performed in triplicate in three different
occasions.
Alkaline protease assay
Alkaline protease activity within the supernatant fraction of
isolates grown overnight in LB broth was determined by add-
ing 0.5 mL of supernatant to 1.5 mL of assay buffer (20 mM
Tris-HCl, 1 mM CaCl2 buffer, pH 8.0) containing 50 mg of
hide remazol blue powder (Sigma). Tubes were incubated at
37C for 1 h with constant rotation, reactions were stopped
on ice, centrifuged at 4000 g for 5 min and absorbance of the
supernatant was measured at 590 nm [16]. Assays were
performed in triplicate in three different occasions.
Pyocyanin assay
Pyocyanin was extracted from broth cultures of isolates
grown in glycerol alanine minimal medium for 24 h [10]. The
cells were removed by centrifugation and pyocyanin in the
supernatant was extracted into chloroform by mixing 5 mL
of supernatant with 3 mL of chloroform. Pyocyanin was then
reextracted into 1 mL of acidiﬁed water (0.2 M HCl) which
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gave a pink–red solution. For the quantitation of the pyo-
cyanin within the solution, the absorbance was measured at
520 nm [17]. Assays were performed in triplicate in three
different occasions.
Bioﬁlm assay
The bioﬁlm forming ability of the isolates was tested using
polystyrene microtitre plates. Brieﬂy, overnight broth cul-
tures in LB broth were diluted 1:100 into fresh LB broth and
then 0.1 mL of the freshly inoculated medium was dispensed
into wells of a 96-well polystyrene microtitre plate. The plate
was incubated at 37C for 8 h without agitation. Bioﬁlms
were detected by staining the wells with 10 lL of crystal vio-
let [0.1% (w/v) in H2O], after the stain was added the plate
was incubated for another 15 min at room temperature and
then washed thoroughly with distilled water to remove
planktonic cells and residual dye. Ethanol (95%) was used to
elute crystal violet from the bioﬁlms and the absorbance of
the solubilized dye was measured at 590 nm using a microti-
tre plate reader (Labsystems Multiskan MS) [18]. Assays
were performed in triplicate on three different occasions.
Micro-AHL cross-feeding bioassay
To analyse AHL production, a previously presented quantita-
tive microplate assay was used with modiﬁcations [19]. The
assay relies on the induction of pigment production by the
biosensor strains Agrobacterium tumefaciens A136 (most sen-
sitive to 3OC12-HSL) and Chryseobacterium violaceum CV026
(most sensitive to C4-HSL) subsequent to diffusion of the
AHLs into the environment produced by the test organisms.
For this purpose, 200 lL of temperate LB agar was added
into wells of polystyrene microplates (Nunc, Roskilde, Den-
mark) and left to solidify. A. tumefaciens A136 and C. violace-
um CV026 strains were grown in LB agar for 18 h at 30C
and suspensions from two to three colonies were made in
phosphate-buffered saline (PBS) to obtain an OD600 of 0.05
and the wells of the microplate were inoculated with 25 lL of
either C. violaceum CV026 or A. tumefaciens A136 suspensions.
The plates were air dried for 30 min and 20 lL of bacterial
suspensions prepared in PBS were pipetted into each well.
The plates were covered and incubated at 37C for 48 h.
Positive results in each assay were determined by the bluish–
green pigmentation as judged by the unaided eye. Assays were
performed in triplicate in three different occasions.
PCR analysis of the QS genes
Chromosomal DNA was extracted using a commercial kit
(High Pure PCR Template Kit; Roche Diagnostics, Basel,
Switzerland) and oligonucleotide primers designed for lasI,
lasR, rhlI and rhlR genes were used (Fermentas, Glen Burnie,
MD, USA). PCR was performed in 50 lL of reaction mixture
containing 30 ng of chromosomal DNA, 25 lL master mix
(Fermentas), 100 pmol of forward and reverse primers
(1.5 lL each), and H2O. The PCR steps included: initial dena-
turation at 94C for 7 min, followed by 34 cycles of 94C
for 30 s, 50C for 30 s, 72C for 2 min, and ﬁnal extension
at 72C for 10 min. DNA fragments were detected on 1%
agarose gels with ethidium bromide staining [9].
Antimicrobial susceptibility testing
The disk diffusion method of the CLSI was used to deter-
mine the antimicrobial susceptibility of clinical P. aeruginosa
strains (n = 100). The P. aeruginosa strain ATCC 27853 was
used as the internal control [20].
Statistical analysis
The correlation between the production of virulence factors
and antimicrobial susceptibility was evaluated using SPSS soft-
ware (SAS Institute, Cary, NC, USA) with Fisher’s exact test
and p <0.05 was considered statistically signiﬁcant.
Results and Discussion
QS-dependent virulence factors (elastase, alkaline protease,
pyocyanin and bioﬁlm) were assayed in the clinical respira-
tory isolates of P. aeruginosa (n = 100) and the control
strains. Approximately 75% of the isolates were found to
exhibit the QS-dependent phenotypes (Table 1). Sixteen iso-
lates displaying impaired QS-dependent phenotypes were fur-
ther analysed with a micro-AHL cross-feeding bioassay for
the production of the autoinducers 3OC12-HSL and C4-HSL,
and with PCR for the detection of QS genes (lasI, lasR, rhlI
and rhlR). As shown in Table 2, the bioﬁlm forming ability dif-
fered greatly among those isolates, as previously demon-
strated by De´nervaud et al. [10] who failed to detect any
difference in bioﬁlm formation capacity between autoinduc-
er-deﬁcient and -proﬁcient strains. In the present study, both
autoinducers were present in ﬁve isolates (strains 4, 8, 45,
47 and 100), whereas the remaining eleven isolates were
defective either in one or in both of the autoinducers and
considered QS-deﬁcient. In ﬁve of the QS-deﬁcient isolates
that were negative for both autoinducers (strains 31, 70 and
92) or for one autoinducer (strains 81 and 84), all QS genes
were present. Similar to our ﬁndings, Schaber et al. [9] have
also identiﬁed a P. aeruginosa wound isolate with no elastase
and pyocyanin activity, which was negative for both autoin-
ducers but contained all QS genes. In six of our QS-deﬁcient
isolates (strains 21, 27, 39, 60, 83 and 90), one or more of
the QS genes, and in three of them (strains 39, 60 and 83),
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all QS genes failed to amplify with the primers we used. The
lack of PCR ampliﬁcation does not by itself indicate the
absence of QS genes; the target sequences might have dif-
fered substantially from the primer sequences that we used
or the target genes may have been mutated or absent. Con-
versly, the presence of a PCR product does not exclude the
possibility that the QS genes may have had inactivating muta-
tions and this might explain the impaired QS-dependent phe-
notypes observed in the ten isolates in which all four QS
genes were positive with PCR.
Although the production of both autoinducers and all QS
genes were positive in ﬁve of the isolates (strains 4, 8, 45,
47 and 100), they failed to exhibit the QS-dependent pheno-
types. Despite these results obtained in vitro, these strains
could be more virulent at the site of infection in vivo.
Another explanation could be that the regulation of QS
systems is not limited only to lasI/R and rhlI/R, but many
other global regulators are interconnected with the QS
circuitry. The activation of QS requires a critical cell density,
although a quorum of bacteria is not sufﬁcient by itself to
trigger the QS-regulated genes. A comprehensive review on
the regulation of QS in P. aeruginosa is available elsewhere
(21).
Respiratory isolates of P. aeruginosa defective in autoinduc-
er production have also been observed in some other stud-
ies [9–12]. Among 442 P. aeruginosa isolates obtained in one
study from 13 mechanically ventilated patients, nine different
genotypes were identiﬁed; three genotypes were defective in
the production of both AHLs and harboured mutations in
lasR (three stains) and rhlR (two strains) [10]. In another
study of CF patients, only 61% of the P. aeruginosa isolates
were found to produce both autoinducers, whereas 75% of
the isolates produced 3OC12-HSL only and 69% produced
C4-HSL only [11]. Among P. aeruginosa isolates obtained from
critically ill patients with ventilator associated pneumonia,
one-third of the isolates produced lower amounts of autoin-
ducers [12]. Schaber et al. [9] also identiﬁed three P. aerugin-
osa respiratory isolates lacking the AHLs and having
TABLE 2. Investigation of autoinducer production and quorum sensing (QS) genes in clinical respiratory isolates of Pseudomo-
nas aeruginosa showing impaired phenotypic activity in QS-dependent factors (n = 16)
Strain
Autoinducer QS Genes Virulence factorsa
3OC12-HSL C4-HSL lasI lasR rhlI rhlR Elastase
Alkaline
protease Pyocyanin Bioﬁlm
PAO1 + + + + + + 100 100 100 100
PA-04 + + + + + + 0 19 12 56
PA-08 + + + + + + 27 44 16 64
PA-45 + + + + + + 23 5 3 6
PA-47 + + + + + + 6 34 12 1
PA-100 + + + + + + 6 4 2 56
PA-31 ) ) + + + + 3 5 4 24
PA-70 ) ) + + + + 4 1 1 9
PA-81 + ) + + + + 1 1 1 9
PA-84 ) + + + + + 7 0 1 67
PA-92 ) ) + + + + 5 2 23 1
PA-21 ) ) + + ) ) 4 3 31 30
PA-27 ) ) + + ) ) 0 0 21 66
PA-39 ) ) ) ) ) ) 1 6 1 31
PA-60 ) ) ) ) ) ) 1 3 3 6
PA-83 ) ) ) ) ) ) 0 2 1 0
PA-90 + ) + + + ) 3 0 2 10
aValues represent the percentages of the activity of PAO1, the positive control strain whose activity is considered as 100%.
TABLE 1. Results of phenotypic
tests for the investigation of virulence
factor production Virulence factor
Control strains Clinical isolates
PAO1
a
PAO-JP2, -JP3
a
Cut-off
b
Mean
c
Positive (%)
Elastase (A495) 2.557 0.195 0.219 1.162 ± 1.045 76
Alkaline protease (A590) 2.671 0.217 0.241 1.473 ± 1.081 73
Pyocyanin (A520) 0.185 0.035 0.040 0.118 ± 0.033 75
Bioﬁlm (A590) 0.124 0.065 0.076 0.119 ± 0.094 86
aValues are the means of tests performed in triplicate in three different occasions with an SD <10%.
bCut-off values for the evaluation of virulence factor production were determined using the results of nega-
tive control strains PAO-JP2 and -JP3, and deﬁned as mean absorbance value + 2 SD.
cValues are the mean ± SD of tests performed in triplicate in three different occasions for the clinical respira-
tory isolates of Pseudomonas aeruginosa (n = 100).
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mutations in QS-genes. Recent studies indicate that lasR is
the most affected gene in CF patients that accounts for the
ability of P. aeruginosa to adapt to the respiratory environ-
ment as the chronic disease develops [22].
Among our P. aeruginosa respiratory isolates, 15 were
obtained from CF patients and only two (strains 39 and 90)
showed impaired phenotypic activity with accompanying lack
of autoinducer production and QS gene mutations. Heurlier
et al. [23] suggested that the maintenance of a functional QS
has ﬁtness penalty in situations where such functions are not
required. On the other hand, a lasR negative mutant could
also be ﬁtter than the wild-type in certain circumstances,
such as in mixed P. aeruginosa infections where a QS-compe-
tent strain might provide the necessary virulence factors for
the co-colonizing QS-negative strain. Ko¨hler et al. [24] sup-
port this approach, suggesting that rapid adaptation is the
massive ﬁtness advantage of the lasR mutants, gained by
exploiting the cooperating wild-type population without con-
tributing to the public good.
A striking observation in the present study was the corre-
lation between deﬁciency in virulence factor production and
decreased susceptibility to antimicrobials. The isolates that
were negative for virulence factor production were generally
less susceptible to antimicrobials and statistically signiﬁcant
correlations were observed for some agents. This included a
lack of elastase production and resistance to piperacillin and
ceftazidime, failure of alkaline protease production and resis-
tance to tobramycin, piperacillin, piperacillin-tazobactam,
cefepime, imipenem and ciproﬂoxacin, and failure of pyocya-
nin production and resistance to amikacin, tobramycin, ceft-
azidime, ciproﬂoxacin and oﬂoxacin (Table 3). Considering
the fact that bioﬁlm production is partly controlled by QS
and that the standard disk diffusion method does not reﬂect
the susceptibilities of bacteria within a bioﬁlm, the relation-
ship between bioﬁlm production and antimicrobial suscepti-
bility was not added to the Table 3.
QS and antimicrobial susceptibility are closely related in
P. aeruginosa. Efﬂux pump systems, which actively expel
antimicrobials out the cell, contribute greatly to the intrinsic
and acquired resistance of the bacterium. P. aeruginosa cells
are freely permeable to C4-HSL but 3OC12-HSL requires
active efﬂux. The MexAB-OprM efﬂux system has shown to
be involved in active efﬂux of 3OC12-HSL [25]. Evans et al.
[26] demonstrated that strains overexpressing the MexAB-
OprM efﬂux secrete less 3OC12-HSL, pyocyanin, elastase
and casein protease compared to wild-type. In agreement
with our ﬁndings, Ko¨hler et al. [27] reported that mutants
overexpressing the MexEF-OprN efﬂux system produced
lower levels of QS-dependent virulence factors, pyocyanin,
elastase and rhamnolipids.
In conclusion, we suggest that QS-deﬁcient P. aeruginosa
strains may produce respiratory infections and tend to be
less susceptible to antimicrobials. This could be a drawback
for the clinical use of QS-inhibitory drugs that appear supe-
rior to conventional antimicrobials by not exerting any selec-
tive pressure on resistant strains.
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